ANEW Medical - רווח למניה לשנה מתגלגלת KLTO

Klotho Neurosciences Inc (KLTO) develops globally scalable anti-aging therapies, focusing on breakthrough treatments for ALS and Alzheimer's disease. The TTM YoY earnings per share growth rate helps identify market imbalances, with -53.80 serving as the current value of this metric. AI algorithms enhance business efficiency by automating bioinformatic protein analysis, completely eliminating routine laboratory labor.
ANEW Medical, Inc. - פילוחים אנליטיים ומדדי מפתח (KLTO)

Klotho Neurosciences Inc (KLTO) focuses on developing regenerative therapies for Alzheimer's disease, positioning the company as a capital-intensive biotech startup. The current EPS YoY TTM trend reflects the annual change in net income per share over the last 12 months, allowing investors to assess the actual effectiveness of development monetization and the risk of acquiring the asset at the peak of short-term growth.